Last edition
News about "Inflammatory Bowel Disease (IBD)"
NIH Identifies Cells that Protect against Inflammatory Bowel Disease
The National Institutes of Health (NIH) researchers have identified regulatory cells that help protect against Inflammatory Bowel Disease (IBD), a discovery that could lead to improved diagnosis, treatment, and disease management strategies.
Inflammatory Bowel Disease (IBD) | 10/06/2026 | By News Bureau | 129
Mabwell's 9MW5211 Gains NMPA IND Clearance for Inflammatory Bowel Disease
Mabwell’s 9MW5211 has received IND clearance from China’s NMPA for the treatment of Inflammatory Bowel Disease (IBD). As the first drug candidate globally targeting this novel mechanism to enter clinical development, 9MW5211 represents a significant advancement in the search for innovative therapies for IBD patients.
Inflammatory Bowel Disease (IBD) | 08/06/2026 | By News Bureau
Mabwell Secures FDA Clearance for 9MW5211 Clinical Trial Application
Mabwell receives US Food and Drug Administration (FDA) IND clearance for 9MW5211, a novel antibody therapy being developed for Inflammatory Bowel Disease (IBD) clinical studies.
Inflammatory Bowel Disease (IBD) | 11/05/2026 | By News Bureau | 110
Boehringer and Simcere Partner on Dual-Target IBD Antibody
Boehringer Ingelheim has signed a licence and collaboration deal with Simcere to develop a novel TL1A/IL23p19 bispecific antibody for inflammatory bowel disease, gaining global rights outside greater China, with Simcere eligible for up to €1.058 billion in payments.
Inflammatory Bowel Disease (IBD) | 29/01/2026 | By News Bureau | 129
Merck Expands Tulisokibart Phase-2(b) Trials Across Three Inflammatory Diseases
Tulisokibart is an investigational anti-TL1A monoclonal antibody currently in Phase-3 trials for Ulcerative Colitis and Crohn’s disease, to be studied in hidradenitis suppurativa, radiographic axial spondyloarthritis and Rheumatoid Arthritis.
Inflammatory Bowel Disease (IBD) | 07/10/2025 | By Dineshwori | 549
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy